Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
03/2012
03/14/2012CN102091293B Traditional Chinese medicine composition for treating renal cyst
03/14/2012CN102085349B Preparation method and application of compound barbary wolfberry fruit preparation
03/14/2012CN102058806B Preparation method and application of compound polygonum multiflorum preparation
03/14/2012CN101904859B Rhoifolin and hyperin composition and application of medicines prepared therefrom
03/14/2012CN101745028B Drug for treatment of diabetes and complications thereof and preparation method thereof
03/14/2012CN101559177B Oral Shenyan Kangfu capsule for curing acute nephritis and chronic nephritis and preparation method thereof
03/14/2012CN101559146B Oral Tonglin Paishi capsule for curing urinary calculi and preparation method thereof
03/14/2012CN101366716B Application of Raloxifene compounds in preparing medicament for preventing and controlling benign prostatahyperplasie
03/14/2012CN101361739B Anti-bacteria agent for parenteral administration
03/14/2012CN101306014B Use of brown algae polysaccharide sulfuric acid ester of low molecular weight in preparing medicine for treating diabetic nephropathy
03/13/2012USRE43244 Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use
03/13/2012CA2515574C Aminophosphonic acid derivative, salt thereof, and modulator of s1p receptor
03/13/2012CA2486539C C-aryl glucoside sglt2 inhibitors and method
03/13/2012CA2369074C Ether compounds, compositions, and uses thereof
03/13/2012CA2356779C Cytokine receptor chain
03/08/2012WO2012029722A1 Screening method
03/08/2012WO2012029199A1 Tea bag containing cucurbit seeds
03/08/2012WO2012028647A1 Bicyclic aza heterocycles, and use thereof
03/08/2012US20120059066 Pharmaceutical salts
03/08/2012US20120059040 NOVEL FORMS OF [R-(R*,R*)]-2-(4-FLUOROPHENYL)-beta,delta-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID MAGNESIUM
03/08/2012US20120059015 Novel spiroheterocyclic compounds as mglu5 antagonists
03/08/2012US20120059010 Alpha-helix mimetics and methods relating to the treatment of fibrosis
03/08/2012US20120059008 Dialkylamino alkyl esters of pivagabine as medicaments for the treatment of central nervous system disorders
03/08/2012US20120058986 Di-azetidinyl diamide as monoacylglycerol lipase inhibitors
03/08/2012US20120058969 Cystitis treatment with high dose chondroitin sulfate
03/08/2012US20120058967 Vascular protecting agent having salt-absorption inhibitory activity
03/08/2012US20120058966 Sphingosine Kinase Inhibitor Prodrugs
03/08/2012US20120058944 Bone morphogenetic protein 2 (bmp2) variants with reduced bmp antagonist sensitivity
03/08/2012US20120058941 Glucopyranoside compound
03/08/2012US20120058934 Treatment of diseases
03/08/2012US20120058207 Anti-diabetic nutraceutical composition from palm leaf extract
03/08/2012US20120058205 Compositions and treatment regimes for reducing inflammation, end-organ injury, and/or systemic endotoxemia
03/08/2012US20120058121 Methods and compositions for treating lupus
03/08/2012US20120058119 Human tumor necrosis factor tr21 and methods based thereon
03/08/2012US20120058107 Pyrrolo [3,2-c] pyridine-4-one 2-indolinone protein kinase inhibitors
03/08/2012US20120058089 Treatment of organ injuries and burns using placental stem cells
03/08/2012US20120058055 Gastrorententive oral high dose zinc preparations
03/08/2012CA2809911A1 Bicyclic aza heterocycles, and use thereof
03/07/2012EP2425722A2 Drugs and food products for hypophosphoric normo-, hyper- and hypoproteic diets, and hypophosphoric beverages
03/07/2012EP2425715A1 Treating symptoms of renal disease with selective androgen receptor modulators (SARM)
03/07/2012EP2424861A1 Indole-2-carboxamide derivative
03/07/2012EP2424860A1 Heteroarylthiomethyl pyridine derivative
03/07/2012EP2424549A1 Compositions and methods for treating or preventing urolithiasis and conditions associated therewith
03/07/2012EP2424540A1 Compositions and methods for treating and preventing overactive bladder and conditions associated therewith
03/07/2012EP2424517A1 Sulfamoyl benzoic acid derivatives as trpm8 antagonists
03/07/2012EP1982986B1 Pyrrolopyridazinone compound as pde4 inhibitor
03/07/2012EP1572641B1 Method for production of theR,R (or S,S) configuration of glycopyrronium stereoisomers
03/07/2012EP1519732B1 Use of vasopeptidase inhibitors in the treatment of nephropathy
03/07/2012EP1255738B1 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
03/07/2012CN102366590A Formula and preparation method of traditional Chinese medicine for treating kidney/bladder channel tissue disease
03/07/2012CN102366588A Traditional Chinese medicine for treating nephritis
03/07/2012CN102366586A Chinese herbal medicine for treating kidney deficiency, spleen dampness and headache
03/07/2012CN102366583A Traditional Chinese medicinal preparation for treating middle and old aged male diseases caused by kidney vacuity and preparation method thereof
03/07/2012CN102366577A Chinese herbal medicine used for treating urinary calculus
03/07/2012CN102366490A Chinese herbal medicine for treating prostate cancer
03/07/2012CN102366487A Traditional Chinese medicine composition with functions of warming kidney and invigorating yang, and its preparation method
03/07/2012CN101862390B Chinese composition for treating urinary tract infection
03/07/2012CN101735306B Anti-inflammatory peptide with membrane penetration effect
03/06/2012US8129537 Compounds as PDE IV and TNF inhibitors
03/06/2012US8129407 Hemiasterlin derivatives and uses thereof in the treatment of cancer
03/06/2012US8129405 Quinuclidine derivatives and medicinal compositions containing the same
03/06/2012US8129381 Caspase inhibitors and uses thereof
03/06/2012US8129332 Reagents and methods for smooth muscle therapies
03/06/2012CA2476056C Novel 1,2,3-substituted indolizine derivatives, inhibitors of fgfs, method for making same and pharmaceutical compositions containing same
03/06/2012CA2442694C Osteoprotegerin in milk
03/01/2012WO2012027537A1 Use of a receptor-type kinase modulator for treating polycystic kidney disease
03/01/2012WO2012025055A1 Methods and kits for predicting the risk of diabetes associated complications using genetic markers and arrays
03/01/2012US20120053236 Pharmaceutical composition for diabetic nephropathy and its preparation and application
03/01/2012US20120053228 Splice-region antisense composition and method
03/01/2012US20120053212 Methods of treating humans undergoing injection of a contrast agent
03/01/2012US20120053210 Compounds that modulate intracellular calcium
03/01/2012US20120053206 Substituted 2-oxo- and 2-thioxo-dihydroquinoline-3-carboxamides as KCNQ2/3 modulators
03/01/2012US20120053205 Substituted 2-oxy-quinoline-3-carboxamides as KCNQ2/3 modulators
03/01/2012US20120053203 Substituted 1-oxo-dihydroisoquinoline-3-carboxamides as KCNQ2/3 modulators
03/01/2012US20120053186 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors
03/01/2012US20120053181 Pyrrolidine-derived beta 3 adrenergic receptor agonists
03/01/2012US20120053166 4-Oxadiazol-2-YL-Indazoles as Inhibitors of P13 Kinases
03/01/2012US20120053164 Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd
03/01/2012US20120053156 Compositions and methods for loop diuretics with consistent bioavailability
03/01/2012US20120053147 Thiazolopyrimidinone derivatives as pi3 kinase inhibitors
03/01/2012US20120053123 Natriuretic polypeptides having mutations within their disulfide rings
03/01/2012US20120053113 MANUFACTURE OF INTER-ALPHA-INHIBITOR (IaIp) FROM PLASMA
03/01/2012US20120052132 Compositions and methods for treatment of body weight conditions
03/01/2012US20120052130 Gpr 119 modulators
03/01/2012US20120052088 Pneumococcal vaccine and uses thereof
03/01/2012US20120052072 High affinity human antibodies to human il-4 receptor
03/01/2012US20120052007 Peripheral blood sparc binding antibodies and uses thereof
03/01/2012CA2809633A1 Receptor-type kinase modulator and methods of treating polycystic kidney disease
02/2012
02/29/2012EP2421828A2 Piperidine derivatives as inhibitors of renin
02/29/2012EP2421532A2 Spiperone derivatives and methods of treating disorders
02/29/2012EP2421531A1 Use of nifuratel to treat infections caused by atopobium species
02/29/2012EP2048948B1 Liquid compositions of calcium acetate
02/29/2012EP1669350B1 Piperidine derivatives
02/29/2012EP1572725B1 Chi-conotoxin peptides having a n-terminal pyroglutamic acid
02/29/2012CN1921888B Composition for oral administration of tamsulosin hydrochloride and controlled release granule formulation comprising same
02/29/2012CN102365281A Indolizine derivative and use thereof for medical purposes
02/29/2012CN102365269A Novel therapeutic agent for cognitive impairment
02/29/2012CN102363619A Water soluble protoporphyrin compound and preparation method and use thereof
02/29/2012CN102363033A Traditional Chinese medicine for treating chronic nephritis
02/29/2012CN102363015A Compound detoxifying pill
1 ... 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 ... 562